Viewing nowDiaryl Tablet 2 mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

MFDS item code 200301118 · Notified 2003.12.06 · Insurance code 664600430
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered alone, and in cases where blood sugar control is difficult, it can be used in combination with insulin or other hypoglycemic agents like sulfonylureas or metformin. This helps effectively manage blood sugar levels and improve diabetes symptoms.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect at doses above 4 mg, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, initiate treatment with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. In combination therapy with this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes or those with severe hepatic or renal impairment. Pregnant or breastfeeding women should not take this medication, and caution is needed in patients with severe infections or before and after surgery. Patients with specific genetic problems, such as lactose intolerance, should not take this medication. During the initial treatment phase, the risk of hypoglycemia is high, and blood glucose levels should be closely monitored. Special care should be taken for elderly patients or those with poor nutritional status, irregular meal patterns, or those who frequently consume alcohol. This medication can cause hypoglycemia, so if symptoms such as headache, severe hunger, dizziness, or coma occur, immediate action is required. Vision disturbances or gastrointestinal symptoms, liver function abnormalities, blood disorders, allergic reactions may occur, so if any unusual symptoms arise, consult a doctor immediately. Regular intake along with dietary and exercise therapy is necessary, and if hypoglycemia occurs, intake of sugar should promptly alleviate symptoms. If taken with other medications, drug interactions may occur, so it is important to inform your doctor or pharmacist about any ongoing medications. In cases of pregnancy or breastfeeding, it is safer to switch to insulin therapy rather than taking this medication. The safety and efficacy in children have not been established, and dosage adjustments may be necessary in elderly patients due to decreased renal function. In cases of overdose, severe hypoglycemia may occur, so immediate medical treatment is required, and this medication should be kept out of reach of children.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or initiative, depression, confusion, language disturbances, aphasia, visual impairment, tremors, partial paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased hepatic enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is also advisable to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its efficacy over time.
Green oblong tablet
For domestic use: 100 tablets/bottle, 30 tablets/bottle; For export: 100 tablets/bottle, 30 tablets/bottle, 30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.